Astrobiology Makes Debut Under NASA

With a flourish of the checkbook and a call for research proposals, the National Aeronautics and Space Administration has summoned into prominence a virtually new discipline of science: astrobiology. When the principal investigators of the first 11 member organizations in NASA's Astrobiology Institute gathered on June 10-11 in Washington, D.C., no definition of astrobiology had been formally adopted and no director chosen. Many of the members had never met and knew little or nothing of each oth

Written bySteve Bunk
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

With a flourish of the checkbook and a call for research proposals, the National Aeronautics and Space Administration has summoned into prominence a virtually new discipline of science: astrobiology. When the principal investigators of the first 11 member organizations in NASA's Astrobiology Institute gathered on June 10-11 in Washington, D.C., no definition of astrobiology had been formally adopted and no director chosen. Many of the members had never met and knew little or nothing of each other's research proposals. But $9 million has been allocated through 1999 for funding of this interdisciplinary experiment, which may herald an important change in NASA's approach to investigating life in the universe.

The call for proposals drew 53 responses from universities, research institutes, federal laboratories, private firms, and even five overseas applicants. A panel of 31 independent selectors then chose the institute's member organizations for initial terms of five years. University members are: Harvard ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies